Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Associations between maternal gestational diabetes metformin or insulin treatment and offspring growth trajectories from birth to 60 months of age: Findings from the Born in Bradford ( BiB) study

Title: Associations between maternal gestational diabetes metformin or insulin treatment and offspring growth trajectories from birth to 60 months of age: Findings from the Born in Bradford ( BiB) study
Authors: Martine‐Edith, Gilberte; Johnson, William; Petherick, Emily S.
Contributors: Medical Research Council; NIHR Leicester Biomedical Research Centre; Wellcome Trust; Loughborough University
Source: Diabetic Medicine ; volume 40, issue 11 ; ISSN 0742-3071 1464-5491
Publisher Information: Wiley
Publication Year: 2023
Collection: Wiley Online Library (Open Access Articles via Crossref)
Description: Aim To investigate the associations between gestational diabetes mellitus (GDM) metformin or insulin treatment and offspring growth trajectories from 0 to 60 months. Methods Participants were from the Born in Bradford birth cohort study. Using covariate‐adjusted multilevel linear spline models (4 splines: 0–1.6, 1.6–6, 6–17 and 17–60 months), we compared weight, height and body mass index (BMI) z‐score trajectories of: (1) 76 offspring exposed to metformin (OGDM‐Metformin) and 420 offspring exposed to insulin (OGDM‐Insulin); (2) OGDM‐Metformin and 9171 offspring not exposed to GDM (No‐GDM); (3) OGDM‐Insulin and No‐GDM. Results (1) OGDM‐Metformin had comparable growth trajectories to OGDM‐Insulin from 0 to 60 months. (2) OGDM‐Metformin had a lower mean birthweight z‐score than No‐GDM. OGDM‐Metformin had faster changes in height z‐score (0.13 [95% CI 0.026, 0.24]) from 17 to 60 months and by 60 months, had comparable mean BMI z‐score to No‐GDM. (3) OGDM‐insulin had lower mean birthweight and height z‐scores than No‐GDM. OGDM‐Insulin had faster changes in weight (0.32 [0.021, 0.62]) and height (0.50 [0.087, 0.91]) from 1.6 to 6 months and by 60 months, had comparable mean BMI z‐score to No‐GDM. Conclusions GDM metformin treatment was not associated with differences in offspring growth trajectories compared to insulin treatment. Both metformin and insulin‐exposed offspring had comparable BMI z‐score to No‐GDM by 60 months.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1111/dme.15204
Availability: https://doi.org/10.1111/dme.15204; https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.15204
Rights: http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.907656B5
Database: BASE